1470030719699324930

Yesterday at the @ASH_hematology Annual Meeting & Exposition, we shared one oral and one poster presentation on omidubicel, our lead advanced cell therapy candidate for blood cancers.

Learn more here: https://t.co/G6n15t136e

#ASH21 https://t.co/8lMcUE1Dr8

Send us a message